RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 High-Dose Rosuvastatin Reduces Contrast-Induced Nephropathy
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 2
SP 14
OP 15
DO 10.1177/155989771302006
UL http://mdc.sagepub.com/content/13/2/14.abstract
AB Among statin-naïve patients with non-ST-segment elevation acute coronary syndrome managed with an early invasive strategy, pretreatment with high-dose rosuvastatin was associated with a significant reduction in the incidence of contrast-induced acute kidney injury. In addition, pretreatment with rosuvastatin was also associated with a reduction in adverse clinical events at 30 days compared with placebo. This article presents the results of the Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Acute Kidney Injury and Myocardial Damage in Patients With Acute Coronary Syndrome study [PRATO-ACS; NCT01185938].